European heart journal
Audio Summaries

Temporal comparison of clinical practice and outcomes in heart failure: the JROADHF and JROADHF-NEXT studies

Aug 7, 2026

This study aimed to evaluate the temporal changes in heart failure (HF) management and their impact on patient outcomes by comparing two large-scale Japanese HF registries from 2013 and 2019-21. The findings revealed significant improvements in guideline-recommended therapies and a marked reduction in one-year mortality and HF readmission rates, suggesting that advancements in pharmacotherapy and post-discharge care have positively influenced long-term outcomes for HF patients.

Bruton's tyrosine kinase inhibitors and cardiovascular risk: a meta-analysis

Aug 7, 2026

This meta-analysis investigates the association between Bruton's tyrosine kinase inhibitors (BTK-I) and the risk of incident non-fatal ischaemic major adverse cardiovascular events (MACE) in adults with B-cell malignancies. The study, which included data from 17 Phase 3 randomized controlled trials, found that BTK-I exposure significantly increased the risk of non-fatal ischaemic MACE, with a risk ratio of 1.66. These findings highlight the cardiovascular risks associated with BTK-I treatment, emphasizing the need for careful monitoring in affected patients.

Endometriosis and long-term risk of venous thromboembolism: a Danish nationwide study

Aug 7, 2026

This study aimed to investigate the long-term risk of venous thromboembolism (VTE) in women with endometriosis compared to a matched control group without the condition. The findings revealed that women with endometriosis had a significantly higher incidence of VTE, with an adjusted hazard ratio of 1.52, indicating a notable association between endometriosis and increased thrombotic risk. These results underscore the need for heightened clinical awareness regarding thrombotic complications in women with endometriosis.

Adverse pregnancy outcomes in successive pregnancies and maternal cardiovascular mortality: a Norwegian nationwide study

Aug 5, 2026

The authors aimed to investigate how the sequence of adverse pregnancy outcomes (APOs) and lifetime parity affect maternal cardiovascular disease (CVD) mortality. Analyzing data from over a million women, they found that women with APOs in their first pregnancy had the highest CVD mortality, and the risk varied based on the presence and timing of subsequent pregnancies. The study concludes that evaluating the sequence of APOs provides more nuanced insights into long-term CVD risk compared to a simple binary classification of APO presence.

Periodontitis, epicardial adipose tissue and coronary events: the Swedish Cardiopulmonary Bioimage Study

Aug 5, 2026

This study investigates the relationship between periodontitis and coronary heart disease (CHD), specifically examining whether subclinical atherosclerosis mediates this association and how periodontitis affects epicardial adipose tissue (EAT) as an inflammation marker. The findings reveal that severe periodontitis is linked to increased coronary atherosclerosis, lower EAT attenuation, and a higher risk of incident CHD events, suggesting that periodontitis may serve as a significant marker for cardiovascular risk.

Implementation of cardiac computed tomography in everyday practice

Aug 5, 2026

The authors aim to clarify the role of cardiac computed tomography (CCT) in the clinical management of various heart diseases, including ischaemic heart disease and congenital heart disease. They discuss the clinical indications, prognostic values, limitations, and technical principles of CCT, emphasizing its growing utility in everyday practice for cardiologists. The document also highlights advancements in CCT technology that promise to enhance its application while reducing radiation exposure.

Risk factors and coronary events: attenuation of the association in secondary prevention

Aug 5, 2026

The authors investigate why the associations between risk factors and subsequent coronary heart disease (CHD) events appear weaker or paradoxical in CHD survivors compared to first events. Through a retrospective analysis of health records, they found that while some risk factors maintained consistent associations, many showed diminished or reversed relationships with subsequent events, suggesting that this phenomenon is a systemic issue influenced by index event bias. The study highlights the need for improved methods to understand these associations and emphasizes the importance of not dismissing established therapies based on these findings.

Sex differences in cancer incidence and mortality in patients with cardiovascular disease: the European Prospective Investigation into Cancer-Norfolk study

Aug 5, 2026

The study aimed to investigate sex differences in cancer incidence and mortality among individuals with and without cardiovascular disease (CVD) using data from the European Prospective Investigation into Cancer-Norfolk study. Findings revealed that men had a significantly higher lifetime risk of incident cancer and cancer-related mortality compared to women, particularly among those with CVD, suggesting that comorbidities may mediate these differences.

Mineralocorticoid receptor overactivation in heart failure with preserved ejection fraction

Aug 3, 2026

The authors investigate the role of mineralocorticoid receptor (MR) overactivation in the development and progression of heart failure with preserved ejection fraction (HFpEF), exploring its mechanistic pathways and potential therapeutic interventions. They highlight how MR overactivation contributes to key features of HFpEF and suggest that targeting this pathway with MR antagonists or inhibitors could improve patient outcomes. The paper calls for a reevaluation of treatment strategies in clinical practice to address MR overactivation in HFpEF.

Markers of ultra-processed food and incident arterial hypertension in the UK Biobank

Aug 3, 2026

The authors investigate the association between specific markers of ultra-processed foods (MUPs) and the incidence of arterial hypertension in a cohort of non-hypertensive participants from the UK Biobank. Their findings reveal that certain MUP categories, particularly flavor enhancers, coloring agents, sweeteners, and varieties of sugar, are positively correlated with an increased risk of developing hypertension. This suggests that these MUPs could be targeted in strategies aimed at reducing ultra-processed food consumption to mitigate hypertension risk.